Healthcare - Biotechnology - NASDAQ - US
$ 0.4906
-5.83 %
$ 20.3 M
Market Cap
-0.52
P/E
Price Target
Average
--100.00%
Revenue Forecast
Estimate
35.49%
EBIT
Estimate
24.37%
Net Income
Estimate
24.24%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Spruce Biosciences, Inc.
SPRB has no price targets from Wall Street.
REVENUE FORECAST
Revenue Forecast Chart SPRB
EBIT FORECAST
EBIT Forecast Chart SPRB
NET INCOME FORECAST
Net Income Chart SPRB